PI
-
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial
Stoelinga, A. E. C., Tushuizen, M. E., van den Hout, W. B., Girondo, M. D. M. R., de Vries, E. S., Levens, A. D., Moes, D-J. A. R., Gevers, T. J. G., van der Meer, S., Brouwer, H. T., de Jonge, H. J. M., de Boer, Y. S., Beuers, U. H. W., van der Meer, A. J. & on behalf of the Dutch Autoimmune Hepatitis Group, 1 Dec 2024, In: Trials. 25, 1, 61.Research output: Contribution to journal › Article › Academic › peer-review
-
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
the Dutch Autoimmune Hepatitis Working Group, Apr 2024, In: Journal of Hepatology. 80, 4, p. 576-585 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Socio-economic factors associated with loss to follow-up among individuals with HCV: A Dutch nationwide cross-sectional study
van Dijk, M., Boyd, A., Brakenhoff, S. M., Isfordink, C. J., van Zoest, R. A., Verhagen, M. D., de Knegt, R. J., Drenth, J. P. H. & van der Valk, M., Jan 2024, In: Liver international. 44, 1, p. 52-60 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications